Larry Michael Mertz

Larry Michael Mertz is a declared insider of Accelerate Diagnostics, Inc, with filings sourced from SEC (Form 4). The record holds 18 filings, for trades running from 22 August 2022 to 4 April 2025.

The open-market side counts 2 purchases for €150k alongside 8 sales for €31k. Netting one side against the other leaves €119k of net buying. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Outside the open market, there are 8 option exercises. Since January 2025: no purchases and 1 sale on the market.

On 7 April 2025 came the latest disclosure, an open-market sale for €896 in Accelerate Diagnostics, Inc. The last purchase on record was published on 30 August 2022, which is 1,531 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.